Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study

Nuclear Medicine Communications

Volumn 30, Issue 1, 2009, Pages 41-47

  Castaigne, Catherine ^a   Tondeur, Marianne ^a   De Wit, Stéphane ^a   Hildebrand, Marc ^a   Clumeck, Nathan ^a   Dusart, Michelle ^a  

^a Saint Pierre University Hospital   (France)

Author keywords

Human immunodeficiency virus associated fever of unknown origin; Infection; Malignancy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PYREXIA IDIOPATHICA; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS;

ADULT; FEMALE; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 57749209921     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328310b38d     Document Type: Article

References (13)

1. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 2007; 48:35-45.
2. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, et al. Clinical value of [F-18] fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32:191-196.
3. Bleeker-Rovers CP, De Kleijn E, Corstens FHM, Van der Meer JW, Oyen WJ. Clinical value of FDG-PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31:29-37.
4. Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 2006; 33:913-918.
5. Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 2005; 43:121-134. Review.
6. O'Doherty M, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET Scanning and the human immunodeficiency Virus-positive patient. J Nucl Med 1997; 38:1575-1583.
7. Santiago JF, Jana S, Gilbert HM, Salem S, Bellman PC, Hsu RK, et al. Role of Fluorine-18-fluorodeoxyglucose in the work-up of febrile AIDS patients. Experience with dual head coincidence imaging. Clin Positron Imaging 1999; 2:301-309.
8. Durack DT, Street AC. Fever of unknown origin reexamined and redefined. Curr Clin Top Infect Dis 1991; 11:35-51.
9. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000; 23:75-80.
10. Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216:117-121.
11. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23:739-742.
12. Juweid ME, Cheson BD. Role of positron emission tomography in lymphoma. J Clin Oncol 2005; 23:4577-4580.
13. Juweid ME, Cheson BD. Positron emission tomography and assessment of cancer therapy. N Eng J Med 2006; 354:496-507.